Menu
ncarol.com
  • Home
  • Financial
  • Education
  • Business
  • Nyse
  • Finance
  • Yacht Buyer
  • Stocks
  • Health
ncarol.com

North Carolina: Governor Cooper Announces 325 Jobs as Biopharmaceutical Manufacturer Selects Lee County
ncarol.com/10110921

Trending...
  • Elder Abuse Case Against Healthy Traditions Owner Raises Questions As To The Dire Reality Of Abuse Against The Last Of The Baby Boomers
  • Pure Energy Electrical Services, LLC Announces Strong Start to 2026, Reinforcing Customer-First Electrical Service Across Northeast Florida
  • Notice: Hrm Queen Laurence I Assumes Crown Control & $317q Fund. 3bn Unopoly Shares Settled. Requisition Of Buckingham Palace & Windsor Castle Final
Abzena Holdings (US) LLC, a life sciences contract development and manufacturing organization (CDMO), will locate a significant biopharmaceutical manufacturing site in Lee County, creating 325 jobs and investing $213 million in Sanford, Governor Roy Cooper announced today.

"Abzena recognized North Carolina as a leader in biotechnology and knew this was the right place to develop and manufacture new medicines and grow their business," said Governor Cooper.

Abzena, with headquarters in San Diego, California and sites in Bristol, Pennsylvania and Cambridge, United Kingdom offers its customers solutions in integrated early discovery to mid-phase pharmaceutical production. Working with companies and academic groups from around the world, including many of the top biopharmaceutical brands, Abzena supports the development and manufacture of better treatments for patients.  The company's project in Lee County will establish a state-of-the-art manufacturing facility featuring a design optimized for phase 3 and commercial manufacturing of biologics. Using a phased construction approach, the company will initially build four modular production suites, with each of those suites capable of housing two large bioreactors.

"We are very appreciative for the entire team representing North Carolina for their partnership and the office of U.S. Senator Thom Tillis during the decision process" said Jonathan Goldman MD, CEO of Abzena. "We are delighted to support our customers and the patients they serve with this investment in North Carolina. This builds on the successful launch of our second cGMP biologics facility in San Diego in 2020. We are pleased to provide high quality integrated drug development services covering research as well as the clinical and commercial phases without the need for technology transfer.

More on ncarol.com
  • US Interest Rate Pivot: Hedge Funds Leverage Tickeron AI for 177% Annualized Return
  • Pastor Saeed Abedini Releases THE TRUTH – Volume 1, A Deeply Personal Story of Faith, Struggle, and Redemption
  • New Book Warring From the Standpoint of the Throne Room Calls Believers to Pray From Victory
  • Craigory Dunn & Dre Barracks Release Gospel-Soul Collaboration The Soul Renaissance
  • Why Screen-Fatigued Parents are Choosing the Human Bridge

"Innovative companies set a high bar for excellence, and with today's decision, North Carolina once again meets and exceeds those standards," said North Carolina Commerce Secretary Machelle Baker Sanders. "We welcome Abzena to the state's growing life science industry cluster. As a former executive in this industry myself, it's great to see how North Carolina is leading the way in the product lifecycle for new medicines that will improve and save lives."

Although specific wages will vary depending on job role, the aggregate average salary of the new positions will reach $63,308, bringing $19.1 million of positive payroll impact into the regional economy each year.  The current average wage in Lee County stands at $42,516.

Abzena's project in North Carolina, which will be formally carried out by a new, wholly owned subsidiary company, will be facilitated by a Job Development Investment Grant (JDIG) approved by the state's Economic Investment Committee earlier today. Over the course of the 12-year term of this grant, the project is estimated to grow the state's economy by $1.5 billion. Using a formula that takes into account the new tax revenues generated by the new jobs, the JDIG agreement authorizes the potential reimbursement to the company of up to $6,940,800, spread over 12 years.  Over those 12 years, new state tax revenues generated by the new jobs will exceed $45 million.

State payments only occur following performance verification by the departments of Commerce and Revenue that the company has met its incremental job creation and investment targets. JDIG projects result in positive net tax revenue to the state treasury, even after taking into consideration the grant's reimbursement payments to a given company.

More on ncarol.com
  • Scotch Whisky Market Dislocation Creates Compelling Entry Opportunity for Long-Term Investors
  • Peccioli Becomes New Orleans: In July 2026, the magic of jazz comes to Tuscany
  • Luxur Tequila Introduces a New Standard of Luxury Spirits with Customizable Bottles & Visionary Lea
  • Pepper Moon Catering Awarded Five-Year Single-Award BPA with NC Army National Guard (NC-ARNG)
  • Local Eco-Friendly Cleaning Company Expands Services to Cary, Apex, and Morrisville

Abzena's JDIG agreement could also move as much as $771,200 into a fund that helps rural communities across the state attract business in the future. When companies select a site located in a Tier 2 county such as Lee, their JDIG agreements move some of the new tax revenue into the state's Industrial Development Fund – Utility Account. Local communities in more economically challenged areas of the state use grants from the Utility Account to build public infrastructure projects, which can improve a community's ability to attract companies to their regions.

"We welcome these new biomanufacturing jobs to Lee County," said N.C. Representative John Sauls. "Our region is a vital part of North Carolina's growing life science industry cluster, and we're excited to see the many opportunities that Abzena will bring to our community."

"Many economic development partners worked together to bring this investment to Lee County," said N.C. Senator Jim Burgin. "These community partners will continue to collaborate with Abzena to help the company succeed now and for many years to come."

Partnering with the North Carolina Department of Commerce and the Economic Development Partnership of N.C. on this project were the North Carolina General Assembly, the North Carolina Community College System, the North Carolina Biotechnology Center, the Office of Senator Thom Tillis, Duke Energy, the City of Sanford, Lee County, and the Sanford Area Growth Alliance.


Filed Under: Government, State

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • CCHR: CIA Mind-Control Files Raise Urgent Questions as Millions Take Psychotropic Drugs
  • NRx Pharmaceuticals Launches Breakthrough One-Day Treatment Clinic in Florida as FDA Pathway and Clinical Data Strengthen Growth Outlook; $NRXP
  • Revenue Optics Launches Talent Infrastructure Platform for SaaS Revenue Hiring and Appoints Sabz Kaur to Lead Growth
  • Building a Multi-Domain Autonomous Systems Platform at the Intersection of AI, Defense and Infrastructure: VisionWave Holdings (N A S D A Q: VWAV)
  • Bent Danholm Named "Top Luxury Real Estate Leader" in Modern Luxury Miami
  • Author Ken Mora to Celebrate New Caravaggio Book Debut with Special Event at Palazzo Venezia Naples
  • Matthew Sisneros Releases Raw and Unfiltered Memoir: The Devil Lost Another One — A Powerful Story of Crime, Consequence, and Redemption
  • From Life to Light: Jess L. Martinez Shares a Soulful Poetry Collection That Explores What It Means to Be Human
  • Lawsuit Filed Against Boeing Over Defective Seat Switch on Boeing 787
  • Quadcode Acquires Significant Stake in Game 7, LLC - The Parent Company for FPFX Tech and PropAccount.com
  • Danholm Collection Announces Sale of 16689 Broadwater Ave in Winter Garden, Highlighting Strong Performance in Twinwaters Community
  • Cleveland County Families Choosing to Restore Quality Furniture Instead of Buying New
  • Strong Clinical Results for Breakthrough Liver Diagnostic Platform; ENDRA Life Sciences (N A S D A Q: NDRA) $NDRA
  • 46th International Symposium On Forecasting – Dates, Venue And Speakers Announced
  • Phoenix Rebellion Therapy Celebrates 10 Years Helping Utahns Overcome Trauma as Utah Faces Nation's 2nd-Highest Rate of Mental Health Challenges
  • Bonavita Luxury & Portable Lavatories Announces Rebrand to Bonavita Site Solutions
  • Raleigh Emerges as a Key Player in Sustainable Fashion Innovation for 2026
  • Notice: Hrm Queen Laurence I Assumes Crown Control & $317q Fund. 3bn Unopoly Shares Settled. Requisition Of Buckingham Palace & Windsor Castle Final
  • 13 Full Moons of Black Dandelion Convergent Voice™ An Integration of Literacy & Wellness Symposium
  • Emperor of the Cherokee: A Novel Debuts
_catLbl0 _catLbl1

Popular on ncarol.com

  • Finland's €1.3 Billion Digital Gambling Market Faces Regulatory Tug-of-War as Player Protection Debate Intensifies - 125
  • Still Using Ice? FrostSkin Reinvents Hydration - 112
  • François Arnaud, star of Heated Rivalry, is the real-life inspiration behind Christopher Stoddard's novel At Night Only
  • Diversified Roofing Solutions Strengthens Industry Leadership With Expanded Roofing Services Across South Florida
  • Purple Heart Recipient Honored by Hall of Fame Son In Viral Tribute Sparking National Conversation on Service Fatherhood, Healing and Legacy
  • General Relativity Challenged by New Tension Discovered in Dark Siren Cosmology
  • Cold. Clean. Anywhere. Meet FrostSkin
  • Conexwest Delivers Custom Shipping Container MRI Lab, Saving California Hospital an Estimated $9 Million in Renovation Costs
  • High-Margin Energy & Digital Infrastructure Platform Created after Merger with Established BlockFuel Energy, Innovation Beverage Group (NAS DAQ: IBG)
  • National Expansion Ignited Across Amazon $AMZN, Chewy $CHWY & Walmart $WMT: NDT Pharmaceuticals, Inc. (Stock Symbol: NDTP) $NDTP

Similar on ncarol.com

  • CCHR: CIA Mind-Control Files Raise Urgent Questions as Millions Take Psychotropic Drugs
  • Bonavita Luxury & Portable Lavatories Announces Rebrand to Bonavita Site Solutions
  • CCHR: While Damaging Antipsychotics Win Approval, Proven Non-Drug Alternatives Remain Ignored
  • Arcuri Group Announces Long‑Term Partnership with WakeMed Health & Hospitals to Deliver Situational Awareness and De‑escalation Training
  • IDpack v4 Launches: A Major Evolution in Cloud-Based ID Card Issuance
  • CCHR Says Psychiatry's Admission on Antidepressant Withdrawal Comes Far Too Late
  • Integris Composites developing armor for military in Arctic Circle
  • Delay In Federal Disaster Assistance Causing Failure Of Small Business In Disaster Areas
  • When Representation No Longer Reflects the District — Why I'm Voting for Pete Verbica
  • CCHR: Decades of Warnings, Persistent Inaction; Studies Raise New Alarms on Psychiatric Drug Safety
Copyright © 2026 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute